X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
female (35) 35
index medicus (35) 35
male (34) 34
gastroenterology & hepatology (32) 32
middle aged (32) 32
adult (30) 30
gastroenterology and hepatology (24) 24
hepatitis b (21) 21
aged (20) 20
treatment outcome (17) 17
hepatitis (15) 15
interferon (15) 15
antiviral agents - therapeutic use (14) 14
therapy (14) 14
hepatitis b, chronic - drug therapy (11) 11
hepatitis c (10) 10
hepatitis c virus (10) 10
analysis (9) 9
cirrhosis (9) 9
genotype (9) 9
mortality (9) 9
prospective studies (9) 9
young adult (9) 9
care and treatment (8) 8
dosage and administration (8) 8
drug therapy (8) 8
lamivudine (8) 8
patients (8) 8
risk factors (8) 8
thailand - epidemiology (8) 8
aged, 80 and over (7) 7
clinical trials (7) 7
dna, viral - blood (7) 7
health aspects (7) 7
hepatitis b e antigen (7) 7
hepatitis c, chronic - drug therapy (7) 7
infection (7) 7
liver cirrhosis (7) 7
retrospective studies (7) 7
ribavirin (7) 7
adolescent (6) 6
antiviral agents - adverse effects (6) 6
chronic hepatitis b (6) 6
chronic infection (6) 6
follow-up studies (6) 6
genotypes (6) 6
hepacivirus - genetics (6) 6
liver (6) 6
management (6) 6
medical research (6) 6
medicine, experimental (6) 6
prognosis (6) 6
risk (6) 6
severity of illness index (6) 6
antigens (5) 5
antiviral agents (5) 5
deoxyribonucleic acid--dna (5) 5
disease progression (5) 5
dna (5) 5
drug therapy, combination (5) 5
efficacy (5) 5
genetic aspects (5) 5
hepatitis b virus (5) 5
hepatitis b virus - genetics (5) 5
hepatitis b, chronic - complications (5) 5
hepatology (5) 5
logistic models (5) 5
patient outcomes (5) 5
predictive value of tests (5) 5
research (5) 5
research article (5) 5
thailand (5) 5
alanine transaminase - blood (4) 4
antiviral agents - administration & dosage (4) 4
antiviral therapy (4) 4
cancer (4) 4
cohort studies (4) 4
double-blind method (4) 4
hcv (4) 4
hepatitis b, chronic - virology (4) 4
hepatitis c, chronic - complications (4) 4
incidence (4) 4
infections (4) 4
infectious diseases (4) 4
interferon-alpha - therapeutic use (4) 4
liver cancer (4) 4
liver cirrhosis - complications (4) 4
liver cirrhosis - etiology (4) 4
liver diseases (4) 4
natural-history (4) 4
seroconversion (4) 4
survival (4) 4
tenofovir (4) 4
time factors (4) 4
transcatheter arterial chemoembolization (4) 4
united-states (4) 4
viral-hepatitis (4) 4
virology (4) 4
virus diseases (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Viral Hepatitis, ISSN 1352-0504, 12/2019, Volume 26, Issue 12, pp. 1481 - 1488
Serum hepatitis B virus (HBV) RNA has emerged as a novel biomarker of treatment response. This study aimed to investigate the role of this marker in predicting... 
chronic hepatitis B | stopping rule | virological response | cccDNA | entecavir | HBsAg | pegylated interferon | HBV RNA
Journal Article
Hepatology, ISSN 0270-9139, 11/2014, Volume 60, Issue 5, pp. 1697 - 1707
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2004, Volume 351, Issue 15, pp. 1521 - 1531
Journal Article
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 11/2018, Volume 33, Issue 11, pp. 1822 - 1828
Journal Article
Journal Article
世界肝病学杂志:英文版(电子版), ISSN 1948-5182, 2013, Volume 5, Issue 9, pp. 496 - 504
Hepatitis C genotype 6 is endemic in Southeast Asia[prevalence varies between 10%-60% among all hepatitis C virus(HCV) infection], as well as also sporadically... 
Pegylated | C | therapy | Genotype | Southeast | interferon | Epidemiology | Ribavirin | Hepatitis | Treatment | Response-guided | Asia | 6 | Southeast asia | Pegylated interferon | Hepatitis c | Response-guided therapy | Genotype 6 | Southeast Asia | Minireviews | Hepatitis C
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0173263
Journal Article